Search
Menu
Gentec Electro-Optics Inc   - Measure With Gentec Accuracy LB

Coherent Gets FDA Approvable Letterfor Laser AMD Treatment

Facebook X LinkedIn Email
SANTA CLARA, Calif., Feb. 16 -- Coherent Inc. has received an approvable letter from the US Food and Drug Administration (FDA) for the Opal Photoactivator and Visudyne (Verteporfin for injection) therapy to treat the wet form of age-related macular degeneration (AMD). The disease is the leading cause of blindness in people over the age of 50 in the western world. According to Coherent, the FDA has indicated that it will, following final review, approve the Opal Photoactivator, having concluded that Visudyne therapy is most appropriate for patients with the wet form of AMD, which is...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: February 2000
    diode lasersNews & FeaturesLasers

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.